Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. Co.'s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. We show 59 historical shares outstanding datapoints in our JNJ shares outstanding history coverage, used to compute JNJ market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing JNJ market cap history over the course of time is important for investors
interested in comparing JNJ's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of JNJ versus a peer is one thing; comparing
JNJ market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like JNJ can fluctuate over the course of history.
With this page we aim to empower investors researching JNJ by allowing them to research the JNJ market cap history. |
Free JNJ Email Alerts:
Video: The Importance of Market Cap
